|
In the last year there has taken place a veritable revolution in the field of hair medical treatment. In January 2009 - HairDX, an American company located in California launched the first Genetic Test for the identification of the risk of typical male and female hereditary balding.
HairDX examination is a revolutionary genetic test that identifies changes in the D.N.A continuity of the patient and provides the attending doctor with an advance assessment of the extent of risk of male/female hereditary balding.
The examination reveals the chance of hair-loss years before it begins - many people come for treatment for balding too late (50% of the hair has already fallen out) and early detection increases significantly the chances of success in the treatment of baldness. The significance of the presence of the balding gene in the examination is the increase of the risk to the patient to become bald up to about 70%, and there is a chance of about 30% who will not.
The examination is performed by the taking of a sample from within the mouth (saliva), without any blood test in the U.S.A, and is analysed in an authorised laboratory - the results of the test are hanled with discretion. The sample is sent to the HairDX company and passed on only to the client.
The examination is once-in-a-lifetime - the results are for life.
The examination can be undertaken in Dr. Gibzburg's clinic.
|